ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

UDG Udg Healthcare Public Limited Company

1,079.00
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Udg Healthcare Public Limited Company LSE:UDG London Ordinary Share IE0033024807 ORD EUR0.05 (CDI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,079.00 1,078.00 1,079.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

UDG Healthcare Public Limited Co. Delisting & Cancellation of Trading in UDG Shares (8819I)

17/08/2021 8:56am

UK Regulatory


Udg Healthcare Public (LSE:UDG)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Udg Healthcare Public Charts.

TIDMIRSH TIDMTTM

RNS Number : 8819I

UDG Healthcare Public Limited Co.

17 August 2021

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

17 August 2021

Increased and Final Recommended Cash Offer for

UDG Healthcare plc

by

Nenelite Limited

(a newly incorporated company and Affiliate of Clayton, Dubilier & Rice, LLC, as manager of CD&R Funds X and XI)

to be implemented by way of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014

DELISTING AND CANCELLATION OF TRADING IN UDG SHARES

The listing of UDG Shares on the Official List of the FCA and trading in UDG Shares on the Main Market of the London Stock Exchange has been cancelled with effect from 8.00 a.m. (Dublin time) today, 17 August 2021.

Capitalised terms used, but not defined, in this announcement have the same meaning as in the Revised Scheme Document dated 7 July 2021.

Enquiries:

 
 UDG                                                                Tel: + 353 (0) 1 468 9000 
 Brendan McAtamney / Nigel Clerkin / Damien Moynagh / Keith Byrne 
 Goldman Sachs International (financial adviser to UDG)             Tel: +44 (0) 20 7774 1000 
 Ben Thorpe / Chris Emmerson / Skylar Dabbar 
 
 Rothschild & Co (financial adviser to UDG)                         Tel: +44 (0) 20 7280 5000 
 Hedley Goldberg / Julian Hudson / Ashley Southcott 
 
 Davy (corporate broker and corporate finance adviser to UDG)       Tel: +353 (0) 1 679 7788 
 Ronan Veale / Brian Garrahy 
 
 Liberum (corporate broker to UDG)                                  Tel: +44 (0) 20 3100 2000 
 John Fishley 
 
 Peel Hunt (corporate broker to UDG)                                Tel: +44 (0) 20 7418 8900 
 James Steel 
 
 Powerscourt (PR adviser to UDG)                                    Tel: +44 (0) 20 7250 1446 
 Lisa Kavanagh / Eavan Gannon / Jack Hickey 
 

Statements Required by the Takeover Rules

The UDG Directors accept responsibility for the information contained in this announcement relating to UDG , the UDG Group and the UDG Directors and members of their immediate families, related trusts and persons connected with them. To the best of the knowledge and belief of the UDG Directors (who have taken all reasonable care to ensure that such is the case), the information contained in this announcement for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information.

Goldman Sachs International, which is authorised by the PRA and regulated by the PRA and the FCA in the United Kingdom, is acting as financial adviser to UDG and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than UDG for providing the protections afforded to clients of Goldman Sachs International nor for providing advice in connection with any matter referred to herein. Goldman Sachs International has given, and not withdrawn, its consent to the inclusion of its advice in this announcement in the form and context in which it is included.

N.M. Rothschild and Sons Limited ("Rothschild & Co"), which is authorised and regulated by the FCA in the United Kingdom, is acting as financial adviser to UDG, including providing independent financial advice to the UDG Directors for the purposes of Rule 3 of the Takeover Rules, and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than UDG for providing the protections afforded to clients of Rothschild & Co nor for providing advice in connection with any matter referred to herein. Neither Rothschild & Co nor any of its affiliates (nor their respective directors, officers, employees or agents) owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Rothschild & Co in connection with this announcement, any statement contained herein, the Acquisition or otherwise. Rothschild & Co has given, and not withdrawn, its consent to the inclusion of its advice in this announcement in the form and context in which it is included.

J&E Davy ("Davy"), which is authorised and regulated in Ireland by the Central Bank of Ireland, is acting as corporate broker and corporate finance adviser to UDG and no one else in connection with the matters described in this announcement and will not be responsible to any person for providing the protections afforded to customers of Davy or for advising any other person in connection with any matter referred to herein.

Liberum Capital Limited, which is authorised and regulated by the FCA, is acting as corporate broker to UDG and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than UDG for providing the protections afforded to clients of Liberum Capital Limited nor for providing advice in connection with any matter referred to herein.

Peel Hunt LLP ("Peel Hunt "), which is authorised and regulated in the United Kingdom by the FCA, is acting as corporate broker for UDG and for no one else in connection with the matters referred to in this announcement and will not be responsible to anyone other than UDG for providing the protections afforded to clients of Peel Hunt or for providing advice in connection with any matter referred to herein.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCKZGMRNNKGMZG

(END) Dow Jones Newswires

August 17, 2021 03:56 ET (07:56 GMT)

1 Year Udg Healthcare Public Chart

1 Year Udg Healthcare Public Chart

1 Month Udg Healthcare Public Chart

1 Month Udg Healthcare Public Chart

Your Recent History

Delayed Upgrade Clock